Hudson Bay Capital Management’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,039
Closed -$15.8K 1040
2025
Q1
$15.8K Buy
+2,039
New +$15.8K ﹤0.01% 835
2024
Q2
Sell
-14,400
Closed -$846K 701
2024
Q1
$846K Buy
+14,400
New +$846K ﹤0.01% 464
2023
Q1
Sell
-5,000
Closed -$2M 852
2022
Q4
$2M Sell
5,000
-1,000
-17% -$401K 0.02% 575
2022
Q3
$1.95M Sell
6,000
-1,300
-18% -$423K 0.02% 715
2022
Q2
$1.93M Buy
7,300
+1,700
+30% +$449K 0.01% 773
2022
Q1
$1.68M Buy
5,600
+200
+4% +$60.1K 0.02% 720
2021
Q4
$1.9M Sell
5,400
-200
-4% -$70.5K 0.02% 687
2021
Q3
$1.43M Buy
+5,600
New +$1.43M 0.02% 670
2020
Q4
Sell
-2,400
Closed -$2.47M 609
2020
Q3
$2.47M Sell
2,400
-1,972
-45% -$2.03M 0.04% 318
2020
Q2
$4.43M Buy
4,372
+3,459
+379% +$3.5M 0.08% 207
2020
Q1
$793K Buy
+913
New +$793K 0.02% 341